Medroxyprogesterone acetate and dydrogesterone effect in the treatment of uterine bleeding

Phase 3

• Conditions: vaginal bleeding.; Other abnormal uterine and vaginal bleeding

• Registration Number: IRCT20140111016161N7
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 September 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 176

Inclusion Criteria

Endometrial thickness greater than 5 mm
Simple endometrial hyperplasia

Exclusion Criteria

Endocrine disorders
Anatomical problems;
History of hormone therapy
History of coagulopathy
Contraindication for progestin therapy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Vaginal bleeding. Timepoint: At the beginning of the study (before the intervention) and 3 and 6 months after starting the intervention. Method of measurement: Standard check list designed by the research team.;Endometrium thickness. Timepoint: At the beginning of the study (before the intervention) and 3 and 6 months after starting the intervention. Method of measurement: sonography.;Side effects of treatments. Timepoint: At the beginning of the study (before the intervention) and 3 and 6 months after starting the intervention. Method of measurement: Standard check list designed by the research team.